Author

Kwee Yong

University College LondonORCID 0000-0002-6487-276XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Approach:benchmark study· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Daria Galas‐FilipowicziD· 2 shared Evie Fitzsimons· 2 shared Kane A. FosteriD· 2 shared Karthik RamasamyiD· 2 shared Selina J ChavdaiD· 2 shared Aditya Prabu· 1 shared Alessandro LaganàiD· 1 shared Ambreen RashidiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Daria Galas‐FilipowiczORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Sequential acquisition of 1p31.1-p12 LOH and 1q Gain is a common double-hit event in relapsed/refractory myeloma

Naser Ansari‐Pour, Sarah Gooding, Mohammad H. Kazeroun, Seyed Alireza Hasheminasab, Evie Fitzsimons, Selina J Chavda, Alessandro Laganà, Erin Flynt, Udo C. T. Oppermann, Karthik Ramasamy, Kwee Yong, Angela Hamblin, Jill Corre, Hervé Avet‐Loiseau, Nikhil C. Munshi, , Anjan Thakurta

The paper identifies a therapy-driven genomic double-hit (1pCEN LOH and 1q gain) in relapsed/refractory myeloma, associated with poor prognosis and clonal expansion.

bioRxiv · May 21, 2026 · PreprintCancer Biology

Conserved programs and specificities of T cells targeting hematological malignancies

Tim R. Wagner, Niklas Kehl, Simon Steiger, Tamara Boschert, Michael Kilian, Kane A. Foster, Gabrielle M. Hernandez, Claudia Ctortecka, Julius Michel, Antonia Schach, Julian Zoller, Anna D. Metzler, René Onken, Bruno Schönfelder, Simon Renders, , Mirco Friedrich

This study identifies rare tumor-reactive T cells and conserved antigen repertoires in multiple myeloma and acute myeloid leukemia, developing a TCR fitness model to predict immunotherapy response.

bioRxiv · Aug 7, 2025 · PreprintImmunology

Single-cell profiling of human bone marrow reveals multiple myeloma progression is accompanied by an increase in CD56bright bone marrow resident NK cells.

Elise Rees, Isabella Sodi, Kane A. Foster, Louise Ainley, Emma J. Lyon, Daria Galas‐Filipowicz, Jasmin Rahman, Rebekah Allen, Jessica Kimber, Aditya Prabu, Gwennan Ward, Dylan Jankovic, Annabel Laidler, Bethan Hudson-Lund, Selina J Chavda, , Kwee Yong

The paper shows that multiple myeloma progression is linked to increased CD56bright bone marrow resident NK cells, which may contribute to immune evasion.

bioRxiv · Feb 26, 2025 · PreprintCancer Biology